SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 0-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) | --- | --- | |----------------------------------------- ...

. ● . . Fonar Announces Fiscal 2024 Financial Results September 27, 2024 4:24 PM EDT | Source: Fonar Corporation Total MRI scan volume at the HMCA-managed sites increased 11% to 209,327 scans for the fiscal year ending June 30, 2024 as compared to the prior year. Cash and Cash Equivalents increased 10% to $56.3 million at June 30, 2024 versus the previous fiscal year. Total Revenues - Net increased by 4% to $102.9 million for the fiscal year ended June 30, 2024 versus the previous fiscal year. Income from O ...

FONR Valuation Grade Firstly, the fact that shares of FONR managed to take out their 2021 highs is noteworthy, as this may denote a long-term change in trend in the stock. Secondly, the fact that the recent May lows took place above FONAR's 2023 lows is another encouraging trend. As mentioned, we are waiting for follow-through to the extent of a bullish MACD intermediate crossover followed by a bullish moving-average crossover in due course. Given the end of the stock's trend of lower lows, we believe the a ...

Core Viewpoint - Zacks Investment Research has initiated coverage of FONAR Corporation (FONR) with an "Outperform" recommendation, highlighting the company's strategic initiatives and strong positioning in the MRI diagnostic services market [1] Company Overview - FONAR Corporation, based in Melville, NY, has established a significant presence in the MRI industry, managing 42 MRI scanners as of now, up from nine in 2009 [2] - The company is recognized for developing the first commercial MRI scanner and focuses on designing, manufacturing, selling, and servicing MRI systems, particularly through its Upright MRI technology [2] Financial Performance - For the nine months ending March 31, 2024, FONR reported total revenues increasing by 5.6% and net income rising by 25.3%, indicating effective cost management and strong revenue generation [3] - Income from operations increased by 23.5%, reflecting the company's operational efficiency [3] - As of March 31, 2024, FONAR has total assets of $209.6 million and cash, cash equivalents, and short-term investments totaling $54.1 million [4] - The current ratio improved to 9.37, demonstrating strong liquidity to meet short-term liabilities, while working capital increased by 10.3% to $121.3 million, indicating solid financial health [4] Growth Drivers - Key factors driving FONR's future growth include diversified revenue streams from product sales, service operations, and management fees [5] - The adoption of SwiftMR technology enhances MRI image quality and reduces exam times, contributing to operational efficiency [5] - Strategic expansion efforts, such as opening new Stand-Up MRI centers in Casselberry, FL, and the Bronx, NY, are aimed at meeting rising demand and enhancing service capacity [5] Market Positioning - FONAR's stock has underperformed compared to industry peers and the broader market over the past year, currently trading at low valuation multiples relative to industry standards [7] - This presents a compelling entry point for investors, especially considering FONR's strategic market positioning and potential for profitability improvements [7] Additional Insights - The company has a modest market capitalization of $97.3 million, and the research report aims to provide investors with essential information for decision-making in this promising yet risky market segment [8]

FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 Commission file number 0-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) | DELAWARE | 11-2464137 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 110 Marcus Drive Melville, New York | 11747 | | Address ...

woraput Introduction I recently created a screener on SA for microcap stocks trading below 6x EV/EBITDA and one name that caught my attention was FONAR Corp. (NASDAQ:FONR). The company has a strong balance sheet and I think its Q2 FY24 financial results were strong as TTM EBITDA reached $22.8 million. Yet, its market capitalization has slumped by over 20% in the past month and the EV/EBITDA ratio stands at just 4.2x as of the time of writing. In my view, Fonar is starting to look oversold here, and my ratin ...

FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended DECEMBER 31, 2023 Commission file number 0-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) | DELAWARE | 11-2464137 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 110 Marcus Drive Melville, New York | 11747 | | Addre ...

MFORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2023 Commission file number 000-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) | DELAWARE | 11-2464137 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 110 Marcus Drive Melville, New York | 11747 | | ...

WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 0-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) DELAWARE 11-2464137 (State of incorporation) (IRS Employer Identification Number) 110 Marcu ...

FORM 10-Q SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended MARCH 31, 2023 Commission file number 0-10248 FONAR CORPORATION (Exact name of registrant as specified in its charter) | DELAWARE | 11-2464137 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 110 Marcus Drive Melville, New York | 11747 | | Address of principal executive offices) | (Zip Code) | Registrant's telephone number, including area code: (631) 69 ...